Patents by Inventor Donghong Gao
Donghong Gao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160183075Abstract: A prepaid messaging solution that utilizes a pre-delivery debit query to tariff a short message, coupled with an additional debit query performed once necessary billing information has been acquired. A short message is tariffed prior to message delivery via a pre-delivery debit query to a prepaid server. During message delivery, the prepaid server is queried a second time, following the HLR query performed by the Short Message Service Center (SMSC). This subsequent debit query bills a subscriber for any additional service fees discovered throughout message delivery, e.g., international/roaming fees, etc. If either the pre-delivery debit query or the subsequent debit query indicates that a subscriber has insufficient account balance to deliver a short message, the message is prevented from being delivered. If a message is dropped due to lack of account balance, any funds debited throughout the attempted message delivery may be credited back to the subscriber's prepaid account.Type: ApplicationFiled: February 26, 2016Publication date: June 23, 2016Applicant: TELECOMMUNICATION SYSTEMS, INC.Inventors: DONGHONG GAO, LEWIS TUTTLE
-
Patent number: 9307095Abstract: A prepaid messaging solution that utilizes a pre-delivery debit query to tariff a short message, coupled with an additional debit query performed once necessary billing information has been acquired. A short message is tariffed prior to message delivery via a pre-delivery debit query to a prepaid server. During message delivery, the prepaid server is queried a second time, following the HLR query performed by the Short Message Service Center (SMSC). This subsequent debit query bills a subscriber for any additional service fees discovered throughout message delivery, e.g., international/roaming fees, etc. If either the pre-delivery debit query or the subsequent debit query indicates that a subscriber has insufficient account balance to deliver a short message, the message is prevented from being delivered. If a message is dropped due to lack of account balance, any funds debited throughout the attempted message delivery may be credited back to the subscriber's prepaid account.Type: GrantFiled: August 15, 2014Date of Patent: April 5, 2016Assignee: Telecommunication Systems, Inc.Inventors: Donghong Gao, Lewis Tuttle
-
Publication number: 20150382163Abstract: Text messages with alphanumeric addresses are delivered to mobiles and external short message entities (ESMEs) which do not support alphanumeric addressing, providing meaningful fallback handling. Additionally, the invention enables delivery of SMPP messages from ESME or SMPP networks which can only originate numeric addresses, yet provide for mapping to alphanumeric addresses for delivery to the mobile. A two-way mapping is provided between alphanumeric addresses and SMS short-codes to enable delivery of text messages with alphanumeric addressing in networks which contain mobiles and/or ESME's that lack support of alphanumeric addressing. An ESME can send a text message using an alphanumeric origination address, without knowing which handsets support the capability, and which do not, or whether handsets are on CDMA, or GSM, or UMTS, or long term evolution (LTE) networks, or can continue to send using a numeric origination address.Type: ApplicationFiled: September 11, 2015Publication date: December 31, 2015Inventors: Paul Casto, Lewis Tuttle, Donghong Gao
-
Patent number: 9161184Abstract: Text messages with alphanumeric addresses are delivered to mobiles and external short message entities (ESMEs) which do not support alphanumeric addressing, providing meaningful fallback handling. Additionally, the invention enables delivery of SMPP messages from ESME or SMPP networks which can only originate numeric addresses, yet provide for mapping to alphanumeric addresses for delivery to the mobile. A two-way mapping is provided between alphanumeric addresses and SMS short-codes to enable delivery of text messages with alphanumeric addressing in networks which contain mobiles and/or ESME's that lack support of alphanumeric addressing. An ESME can send a text message using an alphanumeric origination address, without knowing which handsets support the capability, and which do not, or whether handsets are on CDMA, or GSM, or UMTS, or networks, or can continue to send using a numeric origination address. The SMSC provides conversions to alphanumeric addresses on behalf of the ESME and the mobile.Type: GrantFiled: December 23, 2011Date of Patent: October 13, 2015Assignee: TeleCommunications Systems, Inc.Inventors: Paul Casto, Lewis Tuttle, Donghong Gao
-
Publication number: 20140357225Abstract: A prepaid messaging solution that utilizes a pre-delivery debit query to tariff a short message, coupled with an additional debit query performed once necessary billing information has been acquired. A short message is tariffed prior to message delivery via a pre-delivery debit query to a prepaid server. During message delivery, the prepaid server is queried a second time, following the HLR query performed by the Short Message Service Center (SMSC). This subsequent debit query bills a subscriber for any additional service fees discovered throughout message delivery, e.g., international/roaming fees, etc. If either the pre-delivery debit query or the subsequent debit query indicates that a subscriber has insufficient account balance to deliver a short message, the message is prevented from being delivered. If a message is dropped due to lack of account balance, any funds debited throughout the attempted message delivery may be credited back to the subscriber's prepaid account.Type: ApplicationFiled: August 15, 2014Publication date: December 4, 2014Inventors: Donghong Gao, Lewis Tuttle
-
Patent number: 8818330Abstract: A prepaid messaging solution that utilizes a pre-delivery debit query to tariff a short message, coupled with an additional debit query performed once necessary billing information has been acquired. A short message is tariffed prior to message delivery via a pre-delivery debit query to a prepaid server. During message delivery, the prepaid server is queried a second time, following the HLR query performed by the Short Message Service Center (SMSC). This subsequent debit query bills a subscriber for any additional service fees discovered throughout message delivery, e.g., international/roaming fees, etc. If either the pre-delivery debit query or the subsequent debit query indicates that a subscriber has insufficient account balance to deliver a short message, the message is prevented from being delivered. If a message is dropped due to lack of account balance, any funds debited throughout the attempted message delivery may be credited back to the subscriber's prepaid account.Type: GrantFiled: September 5, 2013Date of Patent: August 26, 2014Assignee: TeleCommunication Systems, Inc.Inventors: Donghong Gao, Lewis Tuttle
-
Patent number: 8682289Abstract: A prepaid messaging solution that utilizes a pre-delivery debit query to tariff a short message, coupled with an additional debit query performed once necessary billing information has been acquired. A short message is tariffed prior to message delivery via a pre-delivery debit query to a prepaid server. During message delivery, the prepaid server is queried a second time, following the HLR query performed by the Short Message Service Center (SMSC). This subsequent debit query bills a subscriber for any additional service fees discovered throughout message delivery, e.g., international/roaming fees, etc. If either the pre-delivery debit query or the subsequent debit query indicates that a subscriber has insufficient account balance to deliver a short message, the message is prevented from being delivered. If a message is dropped due to lack of account balance, any funds debited throughout the attempted message delivery may be credited back to the subscriber's prepaid account.Type: GrantFiled: February 14, 2012Date of Patent: March 25, 2014Assignee: TeleCommunication Systems, Inc.Inventors: Donghong Gao, Lewis Tuttle
-
Publication number: 20140006269Abstract: A prepaid messaging solution that utilizes a pre-delivery debit query to tariff a short message, coupled with an additional debit query performed once necessary billing information has been acquired. A short message is tariffed prior to message delivery via a pre-delivery debit query to a prepaid server. During message delivery, the prepaid server is queried a second time, following the HLR query performed by the Short Message Service Center (SMSC). This subsequent debit query bills a subscriber for any additional service fees discovered throughout message delivery, e.g., international/roaming fees, etc. If either the pre-delivery debit query or the subsequent debit query indicates that a subscriber has insufficient account balance to deliver a short message, the message is prevented from being delivered. If a message is dropped due to lack of account balance, any funds debited throughout the attempted message delivery may be credited back to the subscriber's prepaid account.Type: ApplicationFiled: September 5, 2013Publication date: January 2, 2014Applicant: TeleCommunication Systems, Inc.Inventors: Donghong Gao, Lewis Tuttle
-
Patent number: 8586748Abstract: This invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein R1, R2, R4. Ar and Het are as defined herein. The invention also relates to methods of using the compound of formula (I) to treat a diseases and disorders that are mediated or sustained through the activity of CCR10.Type: GrantFiled: April 8, 2009Date of Patent: November 19, 2013Assignee: Boehringer Ingelheim International GmbHInventors: Asitha Abeywardane, Derek Cogan, Younggi Choi, Donghong A. Gao, Daniel R. Goldberg, Alexander Heim-Riether, Craig Andrew Miller, Philip Dean Ramsden, Lana Louise Smith Keenan, Roger John Snow, Yang Yu
-
Patent number: 8552205Abstract: Derivatives of 6,7-dihydro-5H-imidazo[1,2-?]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.Type: GrantFiled: November 20, 2008Date of Patent: October 8, 2013Assignee: Boehringer Ingelheim International GmbHInventors: Antonio Jose del Moral Barbosa, Jr., Joerg Martin Bentzien, Steven Richard Brunette, Zhidong Chen, Derek Cogan, Donghong A. Gao, Alexander Heim-Riether, Joshua Courtney Horan, Jennifer A. Kowalski, Michael David Lawlor, Rene Marc Lemieux, Weimin Liu, Bryan McKibben, Craig Andrew Miller, Neil Moss, Matt Aaron Tschantz, Zhaoming Xiong, Hui Yu, Yang Yu
-
Publication number: 20130045711Abstract: A prepaid messaging solution that utilizes a pre-delivery debit query to tariff a short message, coupled with an additional debit query performed once necessary billing information has been acquired. A short message is tariffed prior to message delivery via a pre-delivery debit query to a prepaid server. During message delivery, the prepaid server is queried a second time, following the HLR query performed by the Short Message Service Center (SMSC). This subsequent debit query bills a subscriber for any additional service fees discovered throughout message delivery, e.g., international/roaming fees, etc. If either the pre-delivery debit query or the subsequent debit query indicates that a subscriber has insufficient account balance to deliver a short message, the message is prevented from being delivered. If a message is dropped due to lack of account balance, any funds debited throughout the attempted message delivery may be credited back to the subscriber's prepaid account.Type: ApplicationFiled: February 14, 2012Publication date: February 21, 2013Inventors: Donghong Gao, Lewis Tuttle
-
Publication number: 20120220320Abstract: Text messages with alphanumeric addresses are delivered to mobiles and external short message entities (ESMEs) which do not support alphanumeric addressing, providing meaningful fallback handling. Additionally, the invention enables delivery of SMPP messages from ESME or SMPP networks which can only originate numeric addresses, yet provide for mapping to alphanumeric addresses for delivery to the mobile. A two-way mapping is provided between alphanumeric addresses and SMS short-codes to enable delivery of text messages with alphanumeric addressing in networks which contain mobiles and/or ESME's that lack support of alphanumeric addressing. An ESME can send a text message using an alphanumeric origination address, without knowing which handsets support the capability, and which do not, or whether handsets are on CDMA, or GSM, or UMTS, or networks, or can continue to send using a numeric origination address. The SMSC provides conversions to alphanumeric addresses on behalf of the ESME and the mobile.Type: ApplicationFiled: December 23, 2011Publication date: August 30, 2012Inventors: Paul Casto, Lewis Tuttle, Donghong Gao
-
Publication number: 20110275800Abstract: This invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein R1, R2, R4. Ar and Het are as defined herein. The invention also relates to methods of using the compound of formula (I) to treat a diseases and disorders that are mediated or sustained through the activity of CCR10.Type: ApplicationFiled: April 8, 2009Publication date: November 10, 2011Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Asitha Abeywardane, Derek Cogan, Younggi Choi, Donghong A. Gao, Daniel R. Goldberg, Alexander Heim-Riether, Craig Andrew Miller, Philip Dean Ramsden, Lana Louise Smith Keenan, Roger John Snow, Yang Yu
-
Publication number: 20110224188Abstract: Derivatives of 6,7-dihydro-5H-imidazo[1,2-?]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.Type: ApplicationFiled: November 20, 2008Publication date: September 15, 2011Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Antonio Jose del Moral Barbosa, Joerg Martin Benzien, Steven Richard Brunette, Zhidong Chen, Derek Cogan, Donghong A. Gao, Alexander Heim-Riether, Joshua Courtney Horan, Jennifer A. Kowalski, Michael David Lawlor, Rene Marc Lemieux, Weimin Liu, Bryan Mckibben, Craig Andrew Miller, Neil Moss, Matt Aaron Tschantz, Zhaoming Xiong, Hui Yu, Yang Yu
-
Patent number: 7790712Abstract: The application relates to compounds of formula Ia and analogues thereof wherein R1 to R13 and X are as defined herein. The invention also relates to the use of the compounds of formula Ia as inhibitors of Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2), and also to a method for preventing or treating a disease or disorder that can be treated or prevented by modulating the activity of MAPKAP-K2 in a subject and to pharmaceutical compositions and kits that include these MAPKAP-K2 inhibitors.Type: GrantFiled: March 17, 2006Date of Patent: September 7, 2010Assignee: Boehringer Ingelheim Pharmaceutical, Inc.Inventors: Derek Cogan, Donghong A. Gao, Daniel R. Goldberg, Craig Andrew Miller, Neil Moss, Matthew Russell Netherton, Philip Dean Ramsden, Zhaoming Xiong
-
Publication number: 20060235017Abstract: Disclosed are compounds of formula (I) Where Ar1, X, Y, Q, W, R3, R4, R5, R6 and Ry are defined herein. The compounds of the invention inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. The compounds are also useful for treating diseases or conditions related to oncology and anticoagulant or fibrinolytic therapy. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.Type: ApplicationFiled: June 27, 2006Publication date: October 19, 2006Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.Inventors: Pier Cirillo, Donghong Gao, Daniel Goldberg, Abdelhakim Hammach, Ming-Hong Hao, Victor Kamhi, Neil Moss, Matthew Netherton, Kevin Qian, Mark Ralph, Lifen Wu, Zhaoming Xiong, Ronald Aungst
-
Publication number: 20060046986Abstract: Disclosed are compounds of formula (I) which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.Type: ApplicationFiled: August 23, 2005Publication date: March 2, 2006Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.Inventors: Donghong Gao, Neil Moss, Ji Wang, Jiang-Ping Wu, Lifen Wu, Zhaoming Xiong
-
Patent number: 6844435Abstract: Disclosed are novel compounds of formula (I): wherein Ar1, X, Y, P, Q and Het are defined herein, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases resulting from inappropriate cell proliferation, which include autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer, as well as conditions resulting from cerebral ischemia, such as stroke. Also disclosed are pharmaceutical compositions comprising these compounds, processes for preparing these compounds and novel intermediate compounds useful in these processes.Type: GrantFiled: October 15, 2002Date of Patent: January 18, 2005Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.Inventors: Roger John Snow, Donghong A. Gao, Daniel R. Goldberg, Abdelhakim Hammach, Daniel Kuzmich, Tina Marie Morwick, Neil Moss, Anthony S. Prokopowicz, III, Robert D. Selliah, Hidenori Takahashi
-
Publication number: 20030207902Abstract: Disclosed are novel compounds of formula (I): 1Type: ApplicationFiled: October 15, 2002Publication date: November 6, 2003Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.Inventors: Roger John Snow, Donghong A. Gao, Daniel R. Goldberg, Abdelhakim Hammach, Daniel Kuzmich, Tina Marie Morwick, Neil Moss, Anthony S. Prokopowicz, Robert D. Selliah, Hidenori Takahashi
-
Patent number: 6489328Abstract: Disclosed are novel compounds of formula (I): wherein Ar1, X, Y, P, Q and Het are defined herein, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases resulting from inappropriate cell proliferation, which include autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer, as well as conditions resulting from cerebral ischemia, such as stroke. Also disclosed are pharmaceutical compositions comprising these compounds, processes for preparing these compounds and novel intermediate compounds useful in these processes.Type: GrantFiled: August 2, 2001Date of Patent: December 3, 2002Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.Inventors: Roger John Snow, Donghong A. Gao, Daniel R. Goldberg, Abdelhakim Hammach, Daniel Kuzmich, Tina Marie Morwick, Neil Moss, Anthony S. Prokopowicz, III, Robert D. Selliah, Hidenori Takahashi